Nectar Lifesciences Ltd (NLL) is a well-integrated pharmaceutical company, manufacturing a diverse range of high-quality pharmaceutical products, including Cephalosporin APIs, finished dosage forms, phytochemicals, and hard gelatin capsules. With production facilities across Punjab, Himachal Pradesh, and Jammu, the company serves a broad customer base in India and over 90 countries globally. Established in 1995, NLL has consistently expanded its production capabilities and product offerings, focusing on oral and sterile cephalosporins and phytochemicals.
Notable milestones include the establishment of a state-of-the-art non-antibiotic therapeutic segment facility in compliance with US-FDA and EDQM guidelines, and the development of innovative products like Nexxicap MintyTM and Nexxicap PearlTM. NLL also engages in contract manufacturing and has a robust international presence with subsidiaries in Sri Lanka, Mauritius, the UK, and the US. Their strategic focus on modernization and capacity expansion positions them as a competitive player in the global pharmaceutical market.
